Document is current
Any future updates will be listed below
-
Authors
Bodansky, Aaron https://orcid.org/0000-0001-8943-8233
Mettelman, Robert C. https://orcid.org/0000-0002-3527-5616
Sabatino, Joseph J. Jr
Vazquez, Sara E.
Chou, Janet
Novak, Tanya https://orcid.org/0000-0002-7115-7545
Moffitt, Kristin L.
Miller, Haleigh S.
Kung, Andrew F.
Rackaityte, Elze https://orcid.org/0000-0003-3889-8082
Zamecnik, Colin R. https://orcid.org/0000-0002-9477-1388
Rajan, Jayant V.
Kortbawi, Hannah
Mandel-Brehm, Caleigh
Mitchell, Anthea
Wang, Chung-Yu
Saxena, Aditi
Zorn, Kelsey https://orcid.org/0000-0003-1227-2137
Yu, David J. L.
Pogorelyy, Mikhail V.
Awad, Walid
Kirk, Allison M. https://orcid.org/0000-0002-4286-3678
Asaki, James
Pluvinage, John V. https://orcid.org/0000-0002-9607-2783
Wilson, Michael R. https://orcid.org/0000-0002-8705-5084
Zambrano, Laura D.
Campbell, Angela P. https://orcid.org/0000-0002-2576-482X
,
Loftis, Laura L.
Hobbs, Charlotte V.
Tarquinio, Keiko M.
Kong, Michele
Fitzgerald, Julie C.
Espinal, Paula S.
Walker, Tracie C.
Schwartz, Stephanie P.
Crandall, Hillary
Irby, Katherine
Staat, Mary Allen
Rowan, Courtney M.
Schuster, Jennifer E.
Halasa, Natasha B.
Gertz, Shira J.
Mack, Elizabeth H.
Maddux, Aline B.
Cvijanovich, Natalie Z.
Zinter, Matt S.
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
Randolph, Adrienne G.
Anderson, Mark S. https://orcid.org/0000-0002-3093-4758
DeRisi, Joseph L. https://orcid.org/0000-0002-4611-9205
- License Information
-
More Information
Article History
Received: 20 June 2023
Accepted: 14 June 2024
First Online: 7 August 2024
Competing interests
: J.L.D. reports being a founder and paid consultant for Delve Bio, Inc., and a paid consultant for the Public Health Company and Allen & Co. M.A.S. receives unrelated research funding from the National Institutes of Health, the Centers for Disease Control and Prevention, Cepheid and Merck and unrelated honoria from UpToDate, Inc. M.R.W. receives unrelated research grant funding from Roche/Genentech and Novartis, and received speaking honoraria from Genentech, Takeda, WebMD and Novartis. J.C. reports consulting fees from GLG group, payments from Elsevier for work as an Associate Editor, a patent pending for methods and compositions for treating and preventing T cell-driven diseases, payments related to participation on a Data Safety Monitoring Board or Advisory Board for Enzyvant, and is a member of the Diagnostic Laboratory Immunology Committee of the Clinical Immunology Society. M.S.Z. receives unrelated funding from the National Heart, Lung, and Blood Institute and consults for Sobi. N.B.H. reports unrelated previous grant support from Sanofi and Quidel, and current grant support from Merck. C.V.H. reports being a speaker for Biofire and a reviewer for UpToDate, Inc. and Dynamed.com. A.G.R. receives royalties as a section editor for Pediatric Critical Care Medicine UpToDate, Inc., and received honoraria for MIS-C-related Grand Round Presentations. A.G.R. is also on the medical advisor board of Families Fighting Flu and is Chair of the International Sepsis Forum, which is supported by industry and has received reagents from Illumina, Inc. P.G.T. is on the Scientific Advisory Board of Immunoscape and Shennon Bio, has received research support and personal fees from Elevate Bio, and consulted for 10X Genomics, Illumina, Pfizer, Cytoagents, Merck and JNJ. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention nor the National Institute of Allergy and Infectious Diseases. All other authors declare no competing interests.
